• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Targeting insulin signaling pathway to develop a new therapy for heart failure.

Research Project

Project/Area Number 15390252
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Circulatory organs internal medicine
Research InstitutionKitasato University

Principal Investigator

SHIOI Tetsuo  Kitasato University, School of Medicine, Department of Internal Medicine and Cardiology, Research Associate, 医学部, 助手 (50360095)

Project Period (FY) 2003 – 2004
Project Status Completed (Fiscal Year 2004)
Budget Amount *help
¥3,600,000 (Direct Cost: ¥3,600,000)
Fiscal Year 2004: ¥2,100,000 (Direct Cost: ¥2,100,000)
Fiscal Year 2003: ¥1,500,000 (Direct Cost: ¥1,500,000)
KeywordsHeart failure / Diabetes / Insulin / Rapamycin / Sirolimus / 心肥大 / 増殖因子
Research Abstract

To develop a new strategy that target insulin signaling, we examined a role of phosphoinositide 3-kinase (PI3K) or mammalian Target of Rapamycin (mTOR) in animal models of heart failure.
1.Effect of rapamycin on a rat model of autoimmune myocarditis.
We administered rapamycin, a selective inhibitor of mTOR, to rats immunized cardiac myosin. Rapamycin improved survival of the rats with autoimmune myocarditis. Rapamycin significantly reduced inflammation and fibrosis. Cardiac contractile function assessed by echocardiography was decreased in myosin immunized rats, and rapamycin preserved cardiac function. Rapamycin significantly attenuated autoimmune myocarditis of rats.
2.Role of PI3K and mTOR in thyroid hormone induced cardiac hypertrophy.
Hyperthyroidism causes cardiac hypertrophy and heart failure. We administered thyroid hormone to wild type mice or transgenic mice expressing dominant-negative PI3K specifically in cardiac muscle cells. Thyroid hormone increased heart weight by 27% in wi … More ld type mice. However, thyroid hormone increased heart weight of dominant-negative PI3K transgenic mice by 9%. We also administered rapamycin to thyroid hormone treated mice. Mice treated with thyroid hormone and rapamycin showed increase in heart weight by 9%. Thus, PI3K and mTOR are necessary for thyroid hormone induced cardiac hypertrophy in mice.
3.Identification of target genes of rapamycin in growing mice hearts.
We administered rapamycin or vehicle to one week old mice. The treatment was continued for a week and the mice were sacrificed. We compared the gene expression profiling using microarray analysis. Expressions of cyclin B3, eukaryotic translation initiation factor 3, stormal cell derived factor 2 like protein were decreased. Expressions of growth arrest specific gene 8, c-myc binding protein, autophagy 12-like protein were increased.
In conclusion, rapamycin significantly attenuated cardiac hypertrophy and heart failure induced by myocarditis and hyperthyroidism. Rapamycin may be a therapeutic modality for heart failure. Less

Report

(3 results)
  • 2004 Annual Research Report   Final Research Report Summary
  • 2003 Annual Research Report
  • Research Products

    (19 results)

All 2005 2004 2003 Other

All Journal Article (14 results) Publications (5 results)

  • [Journal Article] Rapamycin ameliorates experimental autoimmune myocarditis.2005

    • Author(s)
      Maeda K et al.
    • Journal Title

      Int Heart J. 46・3

      Pages: 513-530

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Rapamycin ameliorates experimental autoimmune myocarditis.2005

    • Author(s)
      Maeda K, Shioi T, Kosugi R, Yoshida Y, Takahashi K, Machida Y, Izumi T
    • Journal Title

      Int Heart J. 46

      Pages: 513-530

    • NAID

      130000068505

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Rapamycin ameliorates experimental autoimmune myocarditis2005

    • Author(s)
      Kayo Maeda, Tetsuo Shioi, Rie Kosugi, Yuki Yoshida, Keiko Takahash i, Yoji Machida, Tohru Izumi
    • Journal Title

      International Heart Journal 46・3(in press)

    • NAID

      130000068505

    • Related Report
      2004 Annual Research Report
  • [Journal Article] The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway.2004

    • Author(s)
      MuMullen Jr, Shioi T et al.
    • Journal Title

      J Biol Chem. 279・6

      Pages: 4782-4793

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload.2004

    • Author(s)
      McMullen JR et al.
    • Journal Title

      Circulation 109・24

      Pages: 3050-3055

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy.2004

    • Author(s)
      McMullen JR et al.
    • Journal Title

      Mol Cell Biol. 24・14

      Pages: 6231-6240

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase (p110alpha) pathway.2004

    • Author(s)
      McMullen JR^*, Shioi T^*, Huang WY, Zhang L, Tarnavski O, Bisping E, Schinke M, Kong S, Sherwood MC, Brown J, Riggi L, Kang PM, Izumo S (^*equally contributed)
    • Journal Title

      J Biol Chem. 279

      Pages: 4782-4793

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload.2004

    • Author(s)
      MuMullen JR, Sherwood MC, Tarnavski O, Zhang L, Dorfman AL, Shioi T, Izumo S
    • Journal Title

      Circulation 109

      Pages: 3050-3055

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy.2004

    • Author(s)
      McMullen JR, Shioi T, Zhang L, Tarnavski O, Sherwood MC, Dorfman AL, Longnus S, Pende M, Martin KA, Blenis J, Thomas G, Izumo S
    • Journal Title

      Mol Cell Biol. 24

      Pages: 6231-6240

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Rapamycin attenuates load induced cardiac hypertrophy in mice.2003

    • Author(s)
      Shioi T et al.
    • Journal Title

      Circulation 107・12

      Pages: 1664-1670

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy.2003

    • Author(s)
      McMullen JR et al.
    • Journal Title

      Proc Natl Acad Sci. 107・21

      Pages: 12355-12360

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Rapamycin attenuates load induced cardiac hypertrophy in mice.2003

    • Author(s)
      Shioi T, McMullen JR, Tarnavski O, Converso K, Sherwood MC, Manning WJ, Izumo S
    • Journal Title

      Circulation. 107

      Pages: 1664-1670

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy.2003

    • Author(s)
      McMullen JR, Shioi T, Zhang L, Tarnavski O, Sherwood MC, Kang PM, Izumo S
    • Journal Title

      Proc Natl Acad Sci. 100

      Pages: 12355-12360

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Rapamycin attenuates ventricular remodeling in a rat model of auto immune myocarditis.2003

    • Author(s)
      Kayo Maeda, Tetsuo Shioi
    • Journal Title

      Circulation 108

    • Related Report
      2004 Annual Research Report
  • [Publications] McMullen JR, Shioi T et al.: "The insulin-like growth factor receptor induces physiological heart growth via the phosphoinositide 3-kinase (pllo alpha) pathway."J.Biol.Chem.. 279. 4782-4793 (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Yamamoto K, Shioi T et al.: "Reduced virus induced myocardial injury in ATIR Knockout mice."J.Am.Coll.Cardiol.. 42. 2000-2006 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] MuMullen JR, Shioi T et al.: "Phosphoinositide 3-kinase (pllo alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy"Proc.Natl.Acad.Sci.. 100. 12355-12360 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Shioi T, MuMullen JR et al.: "Rapamycin attenuates load-induced cardiac hypertrophy in mice"Circulation. 107. 1664-1670 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Nishio R, Shioi T et al.: "Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus."J.Am.Coll.Cardiol.. 41. 340-345 (2003)

    • Related Report
      2003 Annual Research Report

URL: 

Published: 2003-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi